Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | PGK1 | P00558 | 6/20 | 0.53 |
| ▸ | PGK2 | P07205 | 6/20 | 0.53 |
| ▸ | LAP3 | P28838 | 3/20 | 0.52 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | ACP3 | P15309 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzylphosphonic Acid SCHEMBL44318 | 0.97 | HPGD (0.60) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL9182484 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL11480034 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL11482013 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL11339355 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL915222 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL11474641 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL5335967 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL11437007 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP | |
| Benzylphosphonic Acid SCHEMBL28910949 | 0.95 | HPGD (0.58) | HPGDPGK1PGK2LAP3ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070219378-A1 | Method for Producing Sodium Fosphenytoin | CILAG AG (CH) | 2007-09-20 | — | — | US | disclosed |
| US-7235666-B2 | Sulfonation of 3-(hydroxymethyl)-5,5-diphenylimidazolidine-2,4-dione followed by phosphating in the presence of trisubstituted aliphatic amine base and a polar aprotic solvent; anticonvulsants, antiepileptic and antiarrhythmia agent | CILAG LTD. (CH) | 2007-06-26 | — | — | US | disclosed |
| US-20050272706-A1 | Process for the preparation of sodium fosphenytoin | CILAG, LTD. | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272706-A1 | Process for the preparation of sodium fosphenytoin | FOS, DUSP5, DCPS | HPGD 1824/4885PGK1 1158/4885PGK2 894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.